•
Jun 30, 2021

ImmunityBio Q2 2021 Earnings Report

Total Revenue
$339K
Previous year: $436K
-22.2%
EPS
-$0.23
Previous year: -$0.2
+15.0%
Gross Profit
$339K
Previous year: $436K
-22.2%
Cash and Equivalents
$84M
Free Cash Flow
-$77.6M
Total Assets
$246M

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment